IRF5 and neoplasm: Furthermore, co-expression of IRF5 and IKKβ (a kinase that phosphorylates and activates IRF5) mediates TAM polarization towards M1 phenotype, supressing tumor development in model systems of advanced-stage ovarian cancer, metastatic melanoma, and glioblastoma [33].